Autophagy in endocrine tumors

Andrea Weckman1, Fabio Rotondo2, Antonio Di Ieva1

  • 1Division of NeurosurgeryDepartment of SurgeryDivision of PathologyDepartment of Laboratory Medicine, St Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8 CanadaDepartment of NeurosurgeryHospital Pablo Tobon Uribe and Clínica Medellin, Medellin, Colombia.

Insights

Autophagy, a cellular process, acts as a double-edged sword in endocrine cancers, impacting tumor suppression and survival. More research is needed to understand its therapeutic potential in these cancers.

Area of Science:

  • Cellular Biology
  • Oncology
  • Endocrinology

Background:

  • Autophagy is a fundamental intracellular degradation process.
  • Its role in cancer is complex, acting as both a tumor suppressor and promoter.
  • Autophagy's function in endocrine cancers is increasingly recognized but not fully understood.

Purpose of the Study:

  • To review the current understanding of autophagy in various endocrine cancers.
  • To highlight the dual role of autophagy in endocrine tumor development and progression.
  • To identify research gaps and emphasize the need for further investigation.

Main Methods:

  • Literature review of existing research on autophagy and endocrine cancers.
  • Analysis of studies investigating autophagy's impact on tumor suppression, survival, and proliferation.
  • Synthesis of findings across different endocrine tumor types.

Main Results:

  • Autophagy exhibits context- and cell-type-dependent effects in endocrine cancers.
  • It presents potential as a therapeutic target, influencing treatment efficacy.
  • Significant research gaps exist, particularly for pancreatic and ovarian endocrine tumors.

Conclusions:

  • Autophagy's role in endocrine cancer is a 'double-edged sword,' requiring careful consideration.
  • Targeting autophagy may offer novel therapeutic strategies for endocrine malignancies.
  • Increased research is crucial to fully elucidate autophagy's mechanisms and therapeutic utility in endocrine oncology.

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K